Clinical trials: Breech Presentation
Pregnancy, Breech Presentation
Effects of Relaxing Hydrotherapy in Third Trimester of Pregnancy
This study will be the first scientific approach to investigate physical and psychological effects of the passive hydrotherapy-method WATSU (WaterShiatsu) on women and their unborn children at the third trimester of pregnancy.
- Conditions
- Pregnancy, Breech Presentation, Low Back Pain, Stress, Psychological
- Trial name
- NCT01708018
- Testing
- WATSU
- Where
- Switzerland
- Volunteers
- 17 people, healthy volunteers welcome
- Sponsor
- Insel Gruppe AG, University Hospital Bern
Breech Presentation
Early External Cephalic Version (ECV) 2 Trial
For women with a fetus in breech presentation, does early ECV (at 34 0/7 up to 35 weeks and 6/7 days) versus delayed ECV (not before 37 weeks and 0/7 days) increase or decrease the likelihood of cesarean section (CS)?
- Trial name
- NCT00141687
- Testing
- Early ECV between 34 0/7 and 35 6/7 weeks, Delayed ECV at or after 37 0/7 weeks
- Where
- Canada
- Volunteers
- 1,543 people
- Sponsor
- McMaster University
Breech Presentation, Pregnancy Complication
Intravenous (IV) Nitroglycerin for Versions in Multiparous Women
Breech presentations (where a baby presents with feet or bottom down) have an increased risk of perinatal and neonatal complications, and are usually delivered by cesarean section.
- Trial name
- INVERT (02) (NCT00901758)
- Testing
- IV Nitroglycerin, Normal saline
- Where
- 3 sites in Canada
- Volunteers
- 44 people
- Sponsor
- University of Calgary
Breech Presentation, Complication of Pregnancy
Intravenous (IV) Nitroglycerin for Versions in Nulliparous Women
Breech presentations (where a baby presents with feet or bottom down) have an increased risk of perinatal and neonatal complications, and are usually delivered by cesarean section.
- Trial name
- INVERT (01) (NCT00896311)
- Testing
- IV Nitroglycerin, Normal saline
- Where
- 3 sites in Canada
- Volunteers
- 82 people
- Sponsor
- University of Calgary
Breech Presentation
Moxibustion for Fetus in Breech Presentation
Objective: To evaluate moxibustion of the BL67 acupoint between 34 and 38 weeks of gestation to facilitate cephalic version of breech presentation in a Western setting.
- Trial name
- NCT00890474
- Testing
- Moxibustion of the BL67 acupoint
- Where
- Switzerland
- Volunteers
- 212 people
- Sponsor
- University Hospital, Geneva
Puerperal Sepsis, Postpartum Hemorrhage
Assessing Childbirth-related Complications at the Community Level in Kenya
Kenya is one of the countries in sub-Saharan Africa that still experience high maternal mortality. For instance, in 2008/09 maternal mortality ratio was estimated to be 488/100,000 live births.
- Conditions
- Puerperal Sepsis, Postpartum Hemorrhage, Preeclampsia and Eclampsia, Retained Placenta, Without Hemorrhage
- Trial name
- NCT01665456
- Where
- Kenya
- Volunteers
- 585 people, healthy volunteers welcome
- Sponsor
- Wilson Liambila